Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Inclusion Criteria:

   - Male and Female Patients at least 18 years old

   - Patient who have rare tumors of neuroendocrine origin, such as tumors of the:

      1. pancreas

      2. pituitary glands

      3. Nelson syndrome

      4. ectopic-ACTH secreting tumor

   - Patients who have failed standard of care treatment or for whom no standard of care
   treatment exist

   - Signed Informed Consent

Exclusion Criteria:

   - Patients with active gallbladder disease

   - Patients with any ongoing or planned anti-neoplastic or interferon therapy

   - Poorly controlled diabetes mellitus

   - Female patients who are pregnant or lactating, or are of childbearing potential and
   not practicing a medically acceptable method of birth control

Other protocol-defined inclusion/exclusion criteria may apply.